Masimo unveils the pediatric indication for O3 regional oximetry with the O3 pediatric sensor. O3 regional oximetry uses near-infrared spectroscopy (NIRS) to continuously monitor absolute and trended regional tissue oxygen saturation (rSO2) in the cerebral region. With the release of the O3 pediatric sensor, O3 regional oximetry monitoring of rSO2 is now available to pediatric patients weighing less than 40 kg (88 lbs.). O3 regional oximetry provides access to valuable data about cerebral oxygen saturation, and studies have shown that the risks of cerebral desaturations include neurological injury, increased length of hospital stays, increased time on mechanical ventilation, and other adverse outcomes. With adult trend accuracy of 3 percent and absolute accuracy of 4 percent without controlling CO2, and trend accuracy of 3 percent in pediatric patients, Masimo O3 should help clinicians build a better picture of brain oxygenation and hopefully better outcomes for all of their patients, including pediatric ones. Masimo O3 regional oximetry and SedLine brain function monitoring are both available on a single platform, Masimo Root - opening up a path to better understanding of the brain.